Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|May 28, 2024
The Real-World Data on Patients With Cardiac Stage IIIb AL AmyloidosisYi Hong, Jinzhou Guo, Wencui Chen, et al.
Transplantation and Cellular Therapy|November 2, 2022
Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal InvolvementFujia Miao, Guisheng Ren, Jinzhou Guo, et al.
Annals of Medicine|April 28, 2022
The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvementLiang Zhao, Guisheng Ren, Jinzhou Guo, et al.
Kidney Diseases (Basel, Switzerland)|March 19, 2026
Long-Term Outcomes in Patients with Renal Systemic Light Chain AmyloidosisYujie Ye, Jinzhou Guo, Wencui Chen, et al.
Kidney Diseases (Basel, Switzerland)|April 18, 2025
Clinical Manifestations and Prognosis of Chronic Kidney Disease after Hematopoietic Stem Cell TransplantationYu Zhang, Guisheng Ren, Wencui Chen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2025
Autologous Hematopoietic Stem Cell Transplantation for Non-AL Amyloidosis Monoclonal Gammopathy of Renal SignificanceMengnan Liu, Liang Zhao, Jinzhou Guo, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 18, 2022
Isoflavones from Semen Sojae Preparatum Improve Atherosclerosis and Oxidative Stress by Modulating Nrf2 Signaling Pathway through Estrogen-Like EffectsJinzhou Guo, Jingxin Ma, Kun Cai, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 21, 2020
The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patientsXianghua Huang, Guisheng Ren, Wencui Chen, et al.
Pageof 3